Immune-Related Adverse Events (irAE) in Cancer Immune Checkpoint Inhibitors (ICI) and Survival Outcomes Correlation: To Rechallenge or Not?

SIMPLE SUMMARY: This study examined the real-world experience and occurrence of immune-related adverse events (irAEs) under cancer checkpoint immunotherapy, and the relationship between its treatment rechallenge status and their impact on clinical outcomes. The current study demonstrates that immune...

Descripción completa

Detalles Bibliográficos
Autores principales: Albandar, Heidar J., Fuqua, Jacob, Albandar, Jasim M., Safi, Salahuddin, Merrill, Samuel A., Ma, Patrick C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956829/
https://www.ncbi.nlm.nih.gov/pubmed/33673446
http://dx.doi.org/10.3390/cancers13050989

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956829/
https://www.ncbi.nlm.nih.gov/pubmed/33673446
http://dx.doi.org/10.3390/cancers13050989

Ejemplares similares